FdaApplication

NDA 219042

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBOEHRINGER INGELHEIM PHARMACEUTICALS INC
application_typeNDA
approval_date2025-08-08

Products (1)

ProductActive ingredientStrengthDosage form
HERNEXEOSZONGERTINIB60MGTABLET;ORAL

1 product